Current Clinical Trials

TREX DME-ML28724

Palmetto Retina - Thursday, July 24, 2014

Sponsor: Genentech

A phase I/II, open-label, multicenter, randomized, controlled study of the safety, tolerability and efficacy of intravitreal injections of 0.3 mg ranibizumab given monthly compared to a Treat and Extend protocol, with and without laser photocoagulation, in patients with Diabetic Macular Edema (T-REX-DME)

Trackback Link
http://www.palmettoretina.com/BlogRetrieve.aspx?BlogID=11185&PostID=504399&A=Trackback
Trackbacks
Post has no trackbacks.

0

Combined Years of Practice

0

Operations Performed

0

Clinical Trials Participated

0

Offices

Our Physicians

Take a few moments to meet the skilled physicians of Palmetto Retina, P.A.

Please Contact Us For More Information

(803) 931-0077 | (888) 931-0077